Biochemix offers end-to-end contract manufacturing services for sterile injectables—covering formulation development, aseptic manufacturing, quality testing, regulatory filing, and PCD franchise distribution under one roof.
We manufacture your branded injectable products end-to-end — under your label, to your specifications, with full GMP batch documentation and regulatory traceability.
Pharmaceutical companies across India and export markets partner with Biochemix to leverage our state-of-the-art injectable manufacturing infrastructure without capital investment. Your formulation, our expertise — produced in WHO-GMP compliant facilities with complete batch manufacturing records, CoA, and regulatory support.
LVP, SVP, Lyophilized, DPI, Cytotoxic, Ophthalmic
Your artwork, your registration, your product
BMR, CoA, deviation reports, retention samples
From pilot batches to commercial-scale production runs
Our integrated manufacturing infrastructure covers the full spectrum of sterile injectable dosage forms, with dedicated lines for each product category in segregated cleanroom environments.
IV infusion solutions manufactured in ISO-validated aseptic filling lines with terminal steam sterilization and 100% integrity testing.
Ampoules and vials from 1–50 mL filled in Grade A laminar airflow. Automated glass welding and capping for hermetic seals.
Freeze-dried powder-for-injection products for temperature-sensitive biologics and oncology drugs requiring enhanced shelf stability.
Aseptic filling of sterile dry powder antibiotics and anti-fungals in Grade A environment under nitrogen atmosphere purge.
Dedicated negative-pressure suites with full personnel protection protocols for oncology injectables and chemotherapy formulations.
Sterile eye drops and intraocular formulations in Grade A with 0.22 µm filtration, preservative-free options, and sealed LDPE delivery.
From API characterization to validation batch, our formulation team develops parenteral formulations with full pharmacopoeial compliance and scale-up readiness.
Our formulation scientists specialize exclusively in injectable dosage forms — aqueous, non-aqueous, lyophilized, and suspension-based parenterals. We use ICH Q8/Q9/Q10 quality-by-design principles throughout development, ensuring your formulation is robust, scalable, and dossier-ready.
ICH Q8, Q9, Q10 framework with design space definition
HPLC, UV, GC methods validated per IP/USP
Complete documentation package for seamless handover
Primary drying, secondary drying, cycle optimization
Our NABL-accredited in-house laboratory performs a complete battery of pharmacopoeial tests on every batch. Nothing ships without a signed CoA.
The Biochemix QC laboratory is equipped with HPLC, UV-Vis spectrophotometer, Karl Fischer titrator, osmometer, endotoxin testing apparatus, and automated visual inspection lines. Stability chambers (ICH Zone IVb) support real-time and accelerated studies. All methods are validated per ICH Q2(R1).
membrane filtration method per IP/USP in isolator-based system
kinetic turbidimetric & gel-clot, NABL certified
light obscuration (HIAC) & visual inspection per IP 2022
ICH-compliant 40°C/75% RH accelerated & 25°C/60% RH real-time
Our regulatory team prepares and files drug dossiers for CDSCO, export registrations, and variation applications — keeping your products compliant across markets.
Navigating India’s pharmaceutical regulatory landscape demands precision and current intelligence. Our RA team brings deep expertise in CDSCO new drug applications, manufacturing license amendments, and export market submissions for GCC, South-East Asia, and African markets.
complete CTD dossier preparation for Form 44 submissions
API and formulation DMFs for reference in partner filings
GCC, Africa, South-East Asia, ASEAN markets
Type I and Type II changes, batch size variation, site transfer
From primary glass selection to cold-chain dispatch, we handle every layer of packaging — print-ready labels, serialized cartons, and temperature-monitored logistics.
Packaging is not an afterthought at Biochemix — it is part of the product specification. We source Type I borosilicate glass, LDPE and PP containers, and work with your artwork team for CDSCO-compliant labeling. Batch coding, online inspection, and serialization are integrated in the packaging line.
ampoules, vials, and prefilled syringes from validated vendors
CDSCO-compliant artwork with batch coding, MRP, and serialization
2–8°C validated packaging for temperature-sensitive injectables
C&F agent network for state-wise distribution to your stockists
A transparent, structured process from first enquiry to your product delivered — with a dedicated project manager at every stage.
Share your formulation brief, target markets, and volume requirements. We sign a mutual NDA and assign a project manager within 24 hours.
Our technical team reviews your formulation for manufacturability. We issue a detailed techno-commercial quotation within 5 working days.
Sign the manufacturing agreement, submit your brand artwork for CDSCO-compliant label design, and provide approved material specifications.
Batch manufactured, QC-tested, and released with full batch documentation. Shipped under temperature-monitored conditions to your warehouse.
Let’s discuss your formulation needs, packaging requirements, and timeline. Partner with Biochemix for hassle-free contract manufacturing.